title: Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy.
authors.forename: W A
authors.initials: WA
authors.lastname: Fahy
authors.forename: E
authors.initials: E
authors.lastname: Farnworth
authors.forename: K P
authors.initials: KP
authors.lastname: Yeldrem
authors.forename: G S
authors.initials: GS
authors.lastname: Melling
authors.forename: D M
authors.initials: DM
authors.lastname: Grennan
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007252:Influenza Vaccines / Q000008:administration & dosage*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D018501:Antirheumatic Agents; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines